Literature DB >> 15582786

The pathogenesis and treatment of brain metastases: a comprehensive review.

Alicia Tosoni1, Mario Ermani, Alba A Brandes.   

Abstract

Brain metastases are the most common intracranial tumors and their incidence is increasing. Untreated brain metastases are associated with a poor prognosis and a poor performance status. The role of surgery in the management of multiple brain metastases is still controversial. As more than 70% of patients have multiple metastases at the time of diagnosis, whole brain radiotherapy is the treatment of choice in most cases. Brain metastases are an ideal target for stereotactic radiosurgery, as they are better circumscribed than primary brain tumors. Currently, chemotherapy has a limited role in the treatment of most brain metastases. Several new therapies, with a good penetration through the blood brain barrier, such as temozolomide, have been used in brain metastases with different results depending on the histology of the primary tumor. A better understanding of the complex processes underlying the development of brain metastasis will enable us to develop more satisfactory targeted treatments.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15582786     DOI: 10.1016/j.critrevonc.2004.08.006

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  34 in total

1.  [Stereotactic radiosurgery for brainstem metastases : In experienced hands a good treatment option with excellent risk-benefit ratio].

Authors:  Zeinab Khademalhosseini; Mitra Khademolhosseini; Berit Kummer; Mechthild Krause
Journal:  Strahlenther Onkol       Date:  2017-04       Impact factor: 3.621

2.  Expression of endoplasmic reticulum stress proteins is a candidate marker of brain metastasis in both ErbB-2+ and ErbB-2- primary breast tumors.

Authors:  Rebeca Sanz-Pamplona; Ramón Aragüés; Keltouma Driouch; Berta Martín; Baldo Oliva; Miguel Gil; Susana Boluda; Pedro L Fernández; Antonio Martínez; Víctor Moreno; Juan J Acebes; Rosette Lidereau; Fabien Reyal; Marc J Van de Vijver; Angels Sierra
Journal:  Am J Pathol       Date:  2011-06-25       Impact factor: 4.307

Review 3.  Brain metastases: an overview.

Authors:  F Bertolini; A Spallanzani; A Fontana; R Depenni; G Luppi
Journal:  CNS Oncol       Date:  2015

4.  Gamma knife radiosurgery for brainstem metastasis.

Authors:  Tae Won Yoo; Eun Suk Park; Do Hoon Kwon; Chang Jin Kim
Journal:  J Korean Neurosurg Soc       Date:  2011-10-31

5.  Utility of claims data for identification of date of diagnosis of brain metastases.

Authors:  Nayan Lamba; Rachel B Kearney; Elie Mehanna; Paul J Catalano; Daphne A Haas-Kogan; Daniel N Cagney; Ayal A Aizer
Journal:  Neuro Oncol       Date:  2020-04-15       Impact factor: 12.300

Review 6.  Neuroimaging of rapidly progressive dementias, part 2: prion, inflammatory, neoplastic, and other etiologies.

Authors:  A J Degnan; L M Levy
Journal:  AJNR Am J Neuroradiol       Date:  2013-02-14       Impact factor: 3.825

Review 7.  In vivo animal models for studying brain metastasis: value and limitations.

Authors:  Inderjit Daphu; Terje Sundstrøm; Sindre Horn; Peter C Huszthy; Simone P Niclou; Per Ø Sakariassen; Heike Immervoll; Hrvoje Miletic; Rolf Bjerkvig; Frits Thorsen
Journal:  Clin Exp Metastasis       Date:  2013-01-16       Impact factor: 5.150

Review 8.  Brain metastases.

Authors:  Susan Lalondrelle; Vincent Khoo
Journal:  BMJ Clin Evid       Date:  2009-03-12

9.  Tissue-engineered microenvironment systems for modeling human vasculature.

Authors:  Anna Tourovskaia; Mark Fauver; Gregory Kramer; Sara Simonson; Thomas Neumann
Journal:  Exp Biol Med (Maywood)       Date:  2014-07-16

10.  Small vessel ischemic disease of the brain and brain metastases in lung cancer patients.

Authors:  Peter J Mazzone; Nicola Marchi; Vince Fazio; J Michael Taylor; Thomas Masaryk; Luke Bury; Tarek Mekhail; Damir Janigro
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.